CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Dec. 16, 2022—Thermo Fisher Scientific launched TrueMark Infectious Disease Research Panels. The analytically sensitive, duplexed TaqMan assays are performed on pre-spotted and dried-down plates that include microorganism-specific pathogens, using real-time PCR techniques, which enables rapid and accurate detection for investigating microorganisms that cause respiratory, vaginal, urinary, gastrointestinal, and sexually transmitted diseases. The predefined and customizable panel options allow researchers to choose from more than 90 different bacterial and viral strain assays to generate results within four hours from taking the samples. Testing can be done from nasopharyngeal swabs or nasopharyngeal aspirate, vaginal, genital, and lesion swabs or urine samples.
The samples can be prepared using workflows that use the Applied Biosystems MagMax viral/pathogen kits automated on a KingFisher purification system instrument and mixed with Applied Biosystems multiplex master mix onto a 96-well or 384-well plate. The panels are optimized for use on QuantStudio qPCR systems and with Applied Biosystems QuantStudio Design and Analysis software v2.6.